Toll-like receptor agonists: a patent review (2011 – 2013)

By Hussein Waleed M   Liu Tzu-Yu   Skwarczynski Mariusz   Toth Istvan  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 453-470

Informa Healthcare

Access to resources Recommend Favorite

New developments around histamine H₃ receptor antagonists/inverse agonists: a patent review (2010 – present)

By Łażewska Dorota   Kieć-Kononowicz Katarzyna  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 89-111

Informa Healthcare

Access to resources Recommend Favorite

Novel prostaglandin receptor modulators – Part II: EP receptor modulators; a patent review (2002 – 2012)

By Flesch Daniel   Merk Daniel   Lamers Christina   Schubert-Zsilavecz Manfred  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 233-267

Informa Healthcare

Access to resources Recommend Favorite

Androgen receptor antagonists: a patent review (2008 – 2011)

By Mohler Michael L   Coss Christopher C   Duke Charles B   Patil Shivaputra A   Miller Duane D   Dalton James T  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 541-565

Informa Healthcare

Access to resources Recommend Favorite

Fluorescent Agonists and Antagonists for Vasopressin/Oxytocin G Protein-Coupled Receptors: Usefulness in Ligand Screening Assays and Receptor Studies

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 996-1005

Bentham Science Publishers

Access to resources Recommend Favorite